- Report
- February 2024
- 50 Pages
Global
From €3171EUR$3,300USD£2,722GBP
- Report
- March 2024
- 188 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- March 2024
- 195 Pages
Global
From €3242EUR$3,374USD£2,783GBP
€3602EUR$3,749USD£3,092GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- November 2023
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- April 2024
- 138 Pages
Global
From €3746EUR$3,899USD£3,216GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,918GBP
- Report
- June 2023
- 241 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Clinical Trials
- April 2024
- 100 Pages
Global
From €2883EUR$3,000USD£2,474GBP
- Drug Pipelines
- April 2024
- 250 Pages
Global
From €2402EUR$2,500USD£2,062GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,031GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,031GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,031GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,237GBP
- Report
- November 2023
- 432 Pages
Global
From €9128EUR$9,500USD£7,836GBP
- Report
- November 2023
- 630 Pages
Global
From €9128EUR$9,500USD£7,836GBP
Docetaxel is a chemotherapy drug used in the treatment of various types of cancer, including breast, ovarian, and non-small cell lung cancer. It is a semi-synthetic derivative of a natural substance found in the bark of the European yew tree. Docetaxel works by interfering with the growth of cancer cells, preventing them from dividing and spreading. It is usually administered intravenously, and is often used in combination with other drugs.
Docetaxel is a widely used oncology drug, and is often prescribed as a first-line treatment for certain types of cancer. It is also used in the treatment of advanced or metastatic cancer, and is sometimes used in combination with other drugs to improve the effectiveness of treatment.
Some companies in the Docetaxel market include Bristol-Myers Squibb, Pfizer, and Sanofi. Show Less Read more